Emergent BioSolutions Inc. Gains 46.85%
Thu, Aug 08, 2024 at 07:15 PM
Emergent BioSolutions Inc. (EBS:NYSE) shot up at $8.4, a gain of 46.9%. On Thu, Aug 08, 2024, EBS:NYSE hit a New 2-Week Intraday Low of $5.67. The stock got featured on our News Catalysts scanner on Thu, Aug 08, 2024 at 08:29 AM in the 'EARNINGS' category. From Thu, Jul 25, 2024, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Tue, Jul 30, 2024 at $15.1 with a volume of 4M+.
About Emergent BioSolutions Inc. (EBS:NYSE)
Emergent BioSolutions Inc is a biotechnology company operating in two divisions: biodefense and biosciences. The company focuses on countermeasures that address public health threats around hematology and oncology therapeutics.
Top 10 Gainers:
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 122.22%
- Kubient Inc. (KBNT:NASDAQ), 100%
- SRAX, Inc. (SRAX:NASDAQ), 100%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
- Digital Turbine, Inc. (APPS:NASDAQ), 61.8%
- Harrow Health, Inc. (HROW:NASDAQ), 54.32%
- MGO Global Inc. (MGOL:NASDAQ), 52.26%
- XPEL, Inc. (XPEL:NASDAQ), 47.69%
- SkyWater Technology Inc. (SKYT:NASDAQ), 47.55%
- Emergent BioSolutions Inc. (EBS:NYSE), 46.85%